Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.
This website is intended for healthcare professionals registered in the Republic of Ireland. By entering this website, you are confirming that you are a healthcare professional registered in the Republic of Ireland. This website may contain professional resources, therapy area materials and promotional information about Novartis Ireland Limited products.